tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
VRTX
Vertex Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRTX full AI Analyst Report?

Vertex Pharmaceuticals (VRTX) Stock News & Sentiment

6,797 Followers
Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
Premium
Weekend Updates
Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
10d ago
NB
ACRS
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
Premium
Company Announcements
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
17d ago
VRTX
Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial
Premium
Company Announcements
Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial
25d ago
VRTX
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
Premium
Ratings
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
1M ago
VRTX
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial
Premium
Market News
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial
1M ago
SION
VRTX
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
Premium
Company Announcements
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
1M ago
VRTX
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
Premium
Ratings
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
1M ago
VRTX
More VRTX News >

VRTX News on the Web

Vertex Pharmaceuticals Incorporated at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis
Insider Monkey
Neutral
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock
The Motley Fool
Bullish
Why CRISPR Therapeutics Stock Rocked the Market Last Month
The Motley Fool
Bullish
Congress Trade: Representative David Taylor Just Disclosed New Stock Trades
Quiver Quantitative
Neutral
Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
TipRanks News
Bullish
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
The Motley Fool
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish

News Score - Last 7 Days

Positive
VRTX
Sector Average
Media Buzz
This Week8 articles
Weekly Average9.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRTX’s Media Buzz Sentiment?
8 articles about VRTX were published this week. In an average week, 9.5 articles are published.
    What is VRTX’s weekly average amount of articles?
    In an average week, 9.5 articles about VRTX are published.
      What is VRTX’s News Sentiment?
      100% of articles about VRTX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SRRKScholar Rock Holding
        SMMTSummit Therapeutics
        BAYRYBayer
        ABBVAbbVie
        KURAKura Oncology
        Showing the stocks with the most bullish news sentiment over the past week